Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
BNBrandi N. WilliamsonFFFriederike FeldmannBSBenjamin SchwarzKMKimberly Meade‐WhiteDPDanielle Porter
National Institutes of Health · National Institute of Allergy and Infectious Diseases · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
739
total citations
- FWCI
- 16.94
- Percentile
- 100%
- References
- 20
Citations per year
Authors
22- BNBrandi N. WilliamsonCorresponding
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- FFFriederike Feldmann
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- BSBenjamin Schwarz
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- KMKimberly Meade‐White
National Institutes of Health, National Institute of Allergy and Infectious Diseases
- DPDanielle Porter
Gilead Sciences (United States)
Topics & keywords
Topics
Keywords
- Medicine
- Rhesus macaque
- Coronavirus
- Virology
- Viral load
- Macaque
- Middle East respiratory syndrome coronavirus
- Lung
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.